Italy· 043042011

PRAMIPEXOLO SANDOZ A/S

A pramipexole product containing pramipexolo, registered in Italy by SANDOZ A/S, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N04BC05

Checked against AIFA (Italy) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pramipexoloAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pramipexole is registered in 18 of 19 countries.

Countries holding a registration under ATC N04BC05 (pramipexole), each read from that country’s own register.

This record: Italy, from AIFA (Italy)
10 of them publish a price we can compare per daily dose

Search pramipexole products by name

Pramipexole · ATC N04BC05

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pramipexole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.28 in United States to $5.68 in Switzerland — a ×20 gap.

Italy: $2.62 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Pramipexole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$5.68
IT Italy$2.62
FR France$1.32
US United States$0.28 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

AIFA (Italy)

Active substance: Pramipexolo
Manufacturer: SANDOZ A/S
Country: Italy (IT)
ATC code: N04BC05
ATC class: Pramipexole
Defined daily dose: 2.5 mg, O
Reimbursed: Yes
Source register: AIFA (Italy)
Last checked: September 28, 2026

Packs & prices · 1

1 priced

aic
043042011
"0,26 MG COMPRESSE A RILASCIO PROLUNGATO" 10 COMPRESSE IN BLISTER OPA-AL-PVC-AL
EUR 2.38

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

197 interactions on record for pramipexole.

Graded by severity as the source publishes them — 51 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pramipexole against other medicines How interaction checks work

Pramipexole · interactions on record

197 records

51 moderate
3 minor
138 info

Most severe, free to view

CimetidineA02BA01moderate
MetoclopramideA03FA01moderate
ThiethylperazinA04AB03moderate
DiphenhydraminA04AB05moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pramipexole in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pramipexole products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Calmolan, Calmolan Retard
Belgium · Pramipexol, Pramipexol Eg
Bulgaria · Parson, Peximyr 0,18 Mg
Cyprus · Medopexol, Rapexole
Czechia · Calmolan, Glepark
Germany · Glepark, Pexapral
Denmark · Glepark, Mariprax
Spain · Pramipexol Aurovitas, Pramipexol Aurovitas Spain
Finland · Pramipexol, Pramipexol Stada
France · Pramipexole Arrow Lab, Pramipexole Biogaran
United Kingdom (Northern Ireland) · Pipexus, Pramipexole Glenmark Pharmaceuticals Europe
Greece · Glepark, Mariprax
Croatia · Pramipeksol Pliva
Hungary · Calmolan, Erimexol
Ireland · Miramel
Iceland · Mirapexin, Oprymea
Liechtenstein · Mirapexin, Pramipexole Teva
Lithuania · Pramipexole Orion
Luxembourg · Pramipexol Eg, Pramipexole Eg
Latvia · Pramipexole Elvim, Pramipexole Orion
Malta · Pramipexole Aurobindo
Netherlands · Glepark, Pramipexol Aurobindo
Norway · Mirapexin, Oprymea
Portugal · Pramipexol Aurobindo, Pramipexol Azevedos
Romania · Pramipexol Arena, Pramipexol Stada
Sweden · Calmolan, Derinik
Slovakia · Glepark, Pramipexol Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c5a7c89c-2e5f-4245-a70b-51d3163ad8f6
GET /v1/drugs/c5a7c89c-2e5f-4245-a70b-51d3163ad8f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"0,26 MG COMPRESSE A RILASCIO PROLUNGATO\" 10 COMPRESSE IN BLISTER OPA-AL-PVC-AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Pramipexolo",
  "reference_pack": "10 UNITA' 0,26 MG - USO ORALE (RILASCIO PROLUNGATO)",
  "public_price_eur": 2.38,
  "ssn_reference_price_eur": 2.38
}

API reference MCP server Plans

See everything about pramipexole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console